Delivery Order SPE2DB22D3301-SPE2DB23FZ3DX
Award Date 8/14/23
Potential Completion Date 8/15/23
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $7,880 to Amerisourcebergen Drug Corporation for the supply of 4562164207 Bromfenac Sodium 0.09% eye drops in 1.7mL bottles. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania between September 13-14, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order without the use of major subcontractors. The funding agency, the Defense...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $9,739 to Amerisourcebergen Drug Corporation for the supply of 4562070970 Bromfenac Sodium 0.09% eye drops in 1.7mL quantities. Performance will occur at the contractor's facility located in Conshohocken, Pennsylvania over a one day period in September 2023. The order is funded through DLA's pharmaceutical procurement programs which leverage competitive contracts to support the medical readiness of the...
- The Defense Logistics Agency awarded a $635.01 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561528596 Bromfenac Sodium 0.09% eye drops. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from July 18, 2023 through July 19, 2023. As the DLA supports the procurement of medical supplies and pharmaceuticals for the Department of Defense, this delivery order is likely providing a specified quantity of the referenced eye...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7ml units, with a ceiling value of $1,873.23. This non-competitive, firm fixed price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7 mL units, with a ceiling value of $1,069.74. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Bromfenac Sodium 0.09% eye drops in 1.7mL units, with a contract ceiling value of $9,699.75. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of May 21, 2025. The delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,328.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bromfenac Sodium 0.09% eye drops (1.7 mL) on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Bromfenac Sodium 0.09% eye drops (1.7 mL) with a ceiling value of $7,904.95. This firm fixed-price delivery order is non-competitive and represents a single pharmaceutical product delivery to support federal medical supply needs. The contract is set to reach ultimate completion by August 13, 2025, with performance conducted from the contractor's corporate office location...
- Defense Logistics Agency awarded a $750 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for Bromfenac Sodium 0.09% eye drops. As the prime contractor, Amerisourcebergen Drug Corp will deliver one point seven milliliter bottles of the eye medication to customers located in Conshohocken, Pennsylvania by September 13, 2023. The parent company of the awardee is Amerisourcebergen Corporation. No set-aside designation was used for this contract award issued by the agency to...
- The Defense Logistics Agency awarded a $2,564 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561931462 Bromfenac Sodium 0.09% eye drops. The one-day contract has a place of performance in Conshohocken, Pennsylvania and supports DLA's medical supply needs. No subcontractors or set aside designations were specified. DLA manages the global supply chain for the military and this order likely provides a needed pharmaceutical to one of the agency's military treatment...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ3DXDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $7,277 to Amerisourcebergen Drug Corporation for the supply of 4561805501 Bromfenac Sodium 0.09% eye drops in 1.7ml bottles. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania, with supplies to be delivered between August 14-15, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to fulfill requirements for this eye medication. No set aside provisions or subcontractors were identified. This award will support the DLA's medical supply chain responsibilities for the U.S. military healthcare system.
Generated 12/24/23, 3:48 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/14/23 |